
Published On: Sep 2020
Published On: Sep 2020
Cryopreserved Amniotic Membrane Segment Held Largest Share of Europe Amniotic Membrane Market in 2019
According to a new market research study of ‘Europe Amniotic Membrane Market to 2027 – Regional Analysis and Forecast by Enzyme, Application and End User,’ the Europe Amniotic Membrane market is expected to reach US$ 742.1 million by 2027 from US$ 434.6million in 2019. The market is estimated to grow with a CAGR of 7.1% from 2020 to 2027. The report provides trends prevailing in the Europe Amniotic Membrane market and the factors driving market along with those that act as hindrances.
Based on the enzyme, the Europe Amniotic Membrane market is segmented into cryopreserved amniotic membrane, dehydrated amniotic membrane. The cryopreserved amniotic membrane segment held the largest share of the market in 2019, and, dehydrated amniotic membrane segment estimated to register the highest CAGR in the market during the forecast period. The growth of cryopreserved amniotic membrane segment the is attributed to rising usage of amniotic membrane drug products along with continuous increase in target population in a Europe region.
The Europe dry eye product market is expected to grow owing to the increasing applications of Amniotic membrane along with rising target population in the region. However, challenges in using amniotic membrane is the retardation factor for the Amniotic Membrane Market.
Applied Biologics LLc, Integra Lifesciences corporation, Skye Biologics LLC, Mimedx are among the leading companies operating in the Europe Amniotic Membrane market.
The report segments Europe Amniotic Membrane Market as Follows:
Europe Amniotic Membrane Market – By Enzyme
Europe Amniotic Membrane Market – By Application
Europe Amniotic Membrane Market– By End User
Europe Amniotic Membrane Market– By Geography